Head start
How to choose the best telemedicine provider for neurology As hospitals navigate the evolving landscape of healthcare, telemedicine has emerged...
adminph
Anocca announces authorisation pancreatic cancer trial
VIDAR-1 trial marks company's clinical-stage debut Anocca has achieved regulatory approval for its first clinical trial, VIDAR-1, a major milestone...
Careology and Entia join forces to transform cancer care
Collaboration brings remote care to cancer patients Careology and Entia have announced a partnership to enhance cancer care through innovative...
Newly identified bacterial protein helps design cancer drug delivery system
A previously unknown protein in a family of bacteria found in soil and the human gut microbiome has been discovered...
Gut bacteria heal the colon
The human gut is home to trillions of bacteria that play vital roles in digestion, immunity, and overall health. When...
Rxulti approved in the European Union for adolescent schizophrenia
EC extends brexpiprazole indication to include adolescents Otsuka Pharmaceutical Europe and Lundbeck have announced that the European Commission has approved...
Grifols clinical trial shows positive results for post-polio patients
Immunoglobulin therapy improves mobility in phase 2/3 study Grifols has announced positive results from its phase 2/3 clinical trial evaluating...
Bayer and Hurdle announce breakthrough in aging research
Bayer and Hurdle have published groundbreaking research that represents a great advancement in aging research. The research introduces and validates...
Minoryx doses first patient with leriglitazone in Rett syndrome study
Phase 2a TREE study assesses safety and efficacy of leriglitazone Minoryx Therapeutics has dosed the first patient in its phase...
Orphelia Pharma explores other pathways for paediatric cancer treatment
Company seeks new direction after negative CHMP opinion on KIZFIZO Orphelia Pharma is exploring alternative regulatory pathways for KIZFIZO after...
Is red wine a healthier choice than white wine? Uncorking the cancer risks
A common perception is that not all alcoholic beverages are alike. Red wine, for instance, is often considered a healthier...
Dementia drug neflamapimod shows positive phase 2b trial results
CervoMed's therapy demonstrates significant improvement in patients CervoMed has announced positive results from the extension phase 2b RewinD-LB study of...
New weight-loss pill shows promising results
Oxford Medical Products targets overweight individuals Oxford Medical Products has announced positive three-month clinical trial results for Sirona, a weight-loss...
Compound found in common herbs inspires potential anti-inflammatory drug for Alzheimer's disease
The herb rosemary has long been linked with memory: "There's rosemary, that's for remembrance," says Ophelia in Shakespeare's Hamlet. So...
Agomab announces positive phase 2a interim results for AGMB-129
FSCD therapy meets all endpoints in interim analysis Agomab Therapeutics NV (Agomab) has announced positive interim results from 44 patients...
Pfizer’s Talzenna therapy accepted for use within NHS Scotland
Scottish Medicines Consortium approves new option for mCRPC patients Pfizer Ltd has announced that the Scottish Medicines Consortium (SMC) has...
Traditional Chinese medicine unlocks new potential in treating diseases through ferroptosis regulation
Innovative insights into the role of ferroptosis, a unique form of programmed cell death, are reshaping the landscape of disease...
NHS urged to offer single pill to all over-50s to prevent heart attacks and strokes
The NHS could prevent thousands more heart attacks and strokes every year by offering everyone in the UK aged 50...
Leqembi enters second consultation period following NICE draft guidance update
NICE convenes third committee meeting for additional appraisal consideration Eisai Europe Ltd. and Biogen Idec Ltd. announced that NICE will...
Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects
A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide - also known as Ozempic - in...
